Streetbeat News

Stock Prices

EVGN

Biomica has announced promising initial results from its Phase 1 clinical trial of BMC128, a microbiome-based immuno-oncology candidate, in combination with Nivolumab for patients with NSCLC, melanoma, or RCC.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 3:02 pm

BTCUSD

Bitcoin's price has fallen by 3.46% over the past 24 hours to $67,666.00, despite a 4.0% uptrend over the past week. Trading volume has increased by 10.0% over the past week, and the circulating supply has grown by 0.14%. Bitcoin's market cap stands at $1.33 trillion.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 3:01 pm

PG

The article provides a comprehensive analysis of Procter & Gamble (NYSE:PG) compared to its competitors in the Household Products industry. Key financial metrics such as P/E, P/B, P/S, ROE, EBITDA, and gross profit are evaluated, highlighting P&G's strengths and weaknesses. The analysis suggests that P&G may be undervalued based on P/E and P/B ratios but potentially overvalued based on P/S ratio. The company's lower ROE and revenue growth, along with higher EBITDA and gross profit, indicate a mixed financial performance.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 3:01 pm

LULU

The article provides an in-depth analysis of Lululemon Athletica (NASDAQ:LULU) compared to its competitors in the Textiles, Apparel & Luxury Goods industry. Key financial metrics indicate that Lululemon has a high valuation but also demonstrates strong financial performance and growth prospects.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 3:00 pm

CSCO

The article provides a comprehensive comparison of Cisco Systems (NASDAQ:CSCO) against its competitors in the Communications Equipment industry. Key financial metrics, market position, and growth prospects are analyzed to offer insights for investors. Cisco shows potential undervaluation based on PE and PB ratios but appears overvalued on PS ratio. The company demonstrates strong profitability with high EBITDA and gross profit but faces challenges with low ROE and declining revenue growth.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 3:00 pm

DNA

Ginkgo Bioworks Holdings (NYSE:DNA) has seen a 7.94% increase in its short percent of float, now at 23.51%. This indicates a bearish sentiment among investors, as it would take traders 5.39 days to cover their short positions. The company's short interest is significantly higher than its peers, whose average is 3.34%.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 3:00 pm

SOLUSD

Solana (SOL) has experienced a 6.22% price drop within the last 24 hours, contrasting with its 7.0% gain over the past week. Trading volume has increased by 21.0%, and the circulating supply has risen by 0.39%, bringing the total to 449.28 million. Solana's market cap is currently ranked #5 at $77.02 billion.

Portfolio Pulse from Benzinga Insights

May 23, 2024 | 3:00 pm

BTCUSD

ETHUSD

The cryptocurrency market experienced a significant downturn as investors awaited the SEC's decision on Ethereum ETFs. Bitcoin dropped by over $2,000, while Ethereum saw a brief dip due to a large sell-off by Symbolic Capital Partners. Market volatility is driven by uncertainty surrounding the SEC's decision, which could either boost or dampen investor confidence.

Portfolio Pulse from Murtuza Merchant

May 23, 2024 | 2:58 pm

NVDA

SPY

The Nasdaq reached all-time highs following strong earnings from NVIDIA and a drop in jobless claims. This positive economic data has boosted investor confidence.

Portfolio Pulse from Benzinga Newsdesk

May 23, 2024 | 2:55 pm

BE

Bloom Energy Corp (NYSE:BE) shares are down 3.29% to $16.44 after announcing a $250 million private offering of green convertible senior notes due 2029. The proceeds will be used to repurchase existing notes and for general corporate purposes. The stock has risen 74.07% over the past month but is currently overbought with an RSI of 90.28.

Portfolio Pulse from Henry Khederian

May 23, 2024 | 2:52 pm